MedTrace Logo

Taiwan ACE Beads for Hepatoma Embolization Therapy

NCT02825550 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2018-08-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the safety and efficacy of Radiopaque Microsphere (T-ACE Beads) interventional therapy for patients with liver cancer

Conditions

  • Cancer of Liver

Interventions

DEVICE

Taiwan ACE Beads

Similar with conventional TACE, radiologist inject lipiodol with doxorubicin first, then use Taiwan ACE Beads instead of Gelfoam or polyvinyl alcohol.

Sponsors & Collaborators

  • The Industrial Technology Research Institute

    collaborator OTHER

  • National Cheng Kung University

    collaborator OTHER

  • National Research Program for Biopharmaceuticals, Taiwan

    collaborator OTHER

  • National Cheng-Kung University Hospital

    lead OTHER

Principal Investigators

  • Xi-Zhang Lin · Department of Internal Medicine, National Cheng Kung University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2016-12-31
Completion
2017-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02825550 on ClinicalTrials.gov